Changes in Hong Kong stocks | Xianruida Medical-B (06669) rose more than 5% in the intraday period. Recently, the microcatheter V-otter registration application was approved

The Zhitong Finance App learned that Xianruida Medical-B (06669) rose more than 5% in the intraday period. As of press release, it had risen 3.25% to HK$13.01, with a turnover of HK$2,449,500.

According to the news, recently, Xianruida Medical-B issued an announcement, and the Group has received approval from the State Drug Administration of China to register the microcatheter V-otter. V-otter is suitable for injecting diagnostic, embolic, or therapeutic materials after reaching the intended vascular site during percutaneous peripheral and coronary vascular interventional procedures. V-otter is a microcatheter used in hepatic artery chemoembolization (TACE). It uses a large lumen design to effectively avoid catheter blockage during surgery; the product provides three head end shaping options: straight, 45° single bend and multiple bends, which can calmly adapt to branching blood vessels at different angles according to actual clinical needs, so as to accurately and stably reach the target blood vessels and prepare for subsequent operations.